# Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors

> **NCT06072989** · PHASE1 · RECRUITING · sponsor: **Shanghai East Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** B4T2-001 autologous CAR-T

## Key facts

- **NCT ID:** NCT06072989
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10
- **Primary completion:** 2025-03
- **Final completion:** 2027-03
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06072989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06072989, "Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06072989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*